CellStormer was established by Dr. Shim and Dr. Lee with the goal of extending life and living a happy life in 2022.

Traditional biological studies have had several limitations on the diagnosis and treatment of intractable diseases. First, the cultivation and differentiation of 2D cells have been difficult to reveal cellular and tissue changes in vivo. In addition, animal testing for actual clinical application had a problem in that it takes a great deal of time and money to verify the safety and effectiveness.

To overcome these problems, using organoids made by 3D culture and differentiation method has attracted the attention of researchers, and research using this can be actively conducted around the various fields including life science research and clinical application.

According to this change in research method, CellStormer is a company that provides R&D and CRO using a 3D platform based on organoid technology that can be used for life science research.

CellStormer can provide alternative 3D platform products or in vitro modeling techniques for the study of various diseases. CellStormer is passionate about providing the highest quality products and researcher support through research and product development in research areas such as cancer, diabetes, and stem cells.